Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol

Authors:
  • OGon behalf of the TULIP (Threshold test using Upper Limit during ImPlantation) Study Group
    on behalf of the TULIP (Threshold test using Upper Limit during ImPlantation) Study Group

Abstract
We evaluated the feasibility of the TULIP (Threshold test using Upper Limit during ImPlantation) protocol, which was designed to provide a confirmed, low defibrillation energy value during implantable cardioverter defibrillator (ICD) implantation with only two induced ventricular fibrillation (VF) episodes. Ninety-eight patients (62 ± 12 years, 86 male) from 13 clinical centres underwent an active can ICD implantation. A single coupling interval derived from electrocardiogram lead II during ventricular pacing was used for VF induction shocks at 13, 11, 9, and 6 J in a step-down manner until the upper limit of VF induction (ULVI) was determined. If ULVI ≥9 J, a defibrillation energy of ULVI + 4 J was tested. For ULVI <9 J, the defibrillation test energy was 9 J. In 79/98 patients (80.6%), two induced VF episodes were sufficient to obtain confirmed defibrillation energy of 11.1 ± 3.3 J. The mean strength of the successful VF induction shock was 6.8 ± 4.3 J, the coupling interval was 303 ± 35 ms, and the number of delivered induction shocks until the first VF induction was 3.9 ± 1.6. TULIP is a safe and simple device testing procedure allowing the determination of confirmed, low defibrillation energy in most patients with two VF episodes induced at a single coupling interval.

This publication has 26 references indexed in Scilit: